Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas - Experience and meta-analysis

Anticancer Research

Volumn 26, Issue 2 B, 2006, Pages 1599-1604

  Van Der Horst Schrivers, Anouk N A ^a   Jager, Pieter L ^a   Boezen, H Marike ^a   Schouten, Jan P ^a   Kema, Ido P ^a   Links, Thera P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

I 123 MIBG scintigraphy; Meta analysis; Phaeochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADRENAL TUMOR; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; MALE; META ANALYSIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RADIODIAGNOSIS; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33645806766     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Lenders JWM, Eisenhofer G, Manneli M and Pacak K: Phaeochromocytoma. Lancet 566: 665-675, 2005.
2. Whalen RK, Althausen AF and Daniels GH: Extra-adrenal pheochromocytoma. J Urol 147: 1-10, 1992.
3. Pacak K, Lineham WM, Eisenhofer G, Walther MM and Goldstein DS: Recent advances in genetics, diagnosis, localization and treatment of pheochromocytoma. Ann Intern Med 134: 315-329, 2001.
4. Goldstein RE, O'Neill JA Jr, Holcomb GW III, Morgan WM III, Neblett WW III, Gates JA, Brown N, Nadeau J, Smith B, Page DL, Abumrad NN and Scot HW Jr: Clinical experience over 48 years with pheochromocytoma. Ann Surg 229: 755-764, 1999.
5. Januszewicz W and Wocial B: Clinical and biochemical aspects of pheochromocytoma: report of 110 cases. Cardiology 72(Suppl 1): 131-136, 1985.
6. Walther MM, Keiser HR and Linehan WM: Pheochromocytoma: evaluation, diagnosis, and treatment. World J Urol 17: 35-39,1999.
7. Neumann HP, Berger DP, Sigmund H, Blum U, Schmidt D, Farmer RJ, Volk B and Kirste G: Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 329: 1531-1538, 1993.
8. Bonjer HJ, Lange JF, Kazemier G, de Herder WW, Steyerberg EW and Bruining HA: Comparison of three techniques for adrenalectomy. Br J Surg 84: 679-682, 1993.
9. Gagner M, Lacroix A, Prinz RA, Boite E, Albala D, Potvin C, Hamet C, Kuchel O, Querin S and Pomp A: Early experience with laparoscopic approach for adrenalectomy. Surgery 114: 1120-1124, 1993.
10. Berglund AS, Hulthen UL, Manhem P, Thorsson O, Wollmer P and Tornquist C: Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas. J Intern Med 249: 247-251, 2001.
11. de Graaf JS, Klooster NJ, de Lange WE, Piers DA and Zwierstra RP: Comparison of iodine scintigraphy and computerized tomography in the localization of pheochromocytoma. Ned Tijdschr Geneeskd 135: 2383-2387, 1991.
12. Furuta N, Kiyota H, Yoshigoe F, Hasegawa N and Ohishi Y: Diagnosis of pheochromocytoma using [123I]-compared with [131I]- metaiodobenzylguanidine scintigraphy. Int J Urol 6: 119-124, 1999.
13. Lucon AM, Pereira MA, Mendonca BB, Halpern A, Wajchenbeg BL and Arap S: Pheochromocytoma: study of 50 cases. J Urol 157: 1208-1212, 1997.
14. Jalil ND, Pattou FN, Combemale F, Chapuis Y, Henry JF, Peix JL and Proye CA: Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE). Eur J Surg 164: 23-28, 1998.
15. Maurea S, Cuocolo A, Reynolds JC, Neumann RD and Salvatore M: Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. Q J Nucl Med 40: 365-371, 1996.
16. Mannelli M, Ianni L, Cilotti A and Conti A: Pheochromocytoma in Italy: a multicentric retrospective study. Eur J Endocrinol 141: 619-624, 1999.
17. Reinig JW, Stutley JE, Leonhardt CM, Spicer KM, Margolis M and Caldwell CB: Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology 792: 41-46, 1994.
18. van Gils AP, Falke TH, van Erkel AR, Arndt JW, Sandler MP, van der Mey AG and Hoogma RP: MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas. Radiographies 11: 37-57, 1991.
19. Honigschnabl S, Gallo S, Niederle B, Prager G, Kaserer K, Lechner G and Heinz-Peer G: How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. Eur J Radiol 41: 113-122, 2002.
20. Wieland DM, Swanson DP, Brown LE and Beierwaltes WH: Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent. J Nucl Med 20: 155-158, 1979.
21. Cheung PS, Thompson NW, Dmuchowski CF and Sisson JC: Spectrum of pheochromocytoma in the 131I-MIBG era. World J Surg 12: 546-551, 1988.
22. Francis IR, Glazer GM, Shapiro B, Sisson JC and Gross BH: Complementary roles of CT and 131I-MIBG scintigraphy in diagnosing pheochromocytoma. AJR 141: 719-725, 1983.
23. Mozley PD, Kim CK, Mohsin J, Jatlow A, Gosfield E, III and Alavi A: The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma. J Nucl Med 35: 1138-1144, 1994.
24. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J and Beierwaltes WH: Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 26: 576-585, 1985.
25. Swensen SJ, Brown ML, Sheps SG, Sizemore GW, Gharib H, Grant CS and van Heerden JA: Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma. Mayo Clin Proc 60: 299-304, 1985.
26. Bravo EL: Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 15: 356-368, 1994.
27. Clesham CJ, Kennedy A, Lavender JP, Dollery CT and Wilkins MR: Meta-iodobenzylguanidine (MIBG) scanning in the diagnosis of phaeochromocytoma. J Hum Hypertens 7: 353-356, 1993.
28. Havlik RJ, Cahow CE and Kinder BK: Advances in the diagnosis and treatment of pheochromocytoma. Arch Surg 123: 626-630, 1988.
29. Lenz T, Gossmann J, Schulte KL, Salewski L and Geiger H: Diagnosis of pheochromocytoma. Clin Lab 48: 5-18, 2002.
30. Maurea S, Cuocolo A, Reynolds JC, Tumeh SS, Begley MG, Linehan WM, Norton JA, Walther MM, Keiser HR and Neumann RD: Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI. J Nucl Med 34: 173-179, 1993.
31. Ilias I and Pacak K: Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 8: 479-491, 2004.
32. de Graaf JS, Dullaart RP, Kok T, Piers DA and Zwierstra RP: Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II. Eur J Surg 166: 289-292, 2000.
33. van der Harst E., de Herder WW, Bruining HA, Bonjer HJ, de Krijger RR, Lamberts SW, van de Meiracker AH, Boomsma F, Stijnen T, Krenning EP, Bosman FT and Kwekkeboom DJ: [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas. J Clin Endocrinol Metab 56: 685-693, 2001.
34. Miskulin J, Shulkin BL, Doherty GM, Sisson JC, Burney RE and Gauger PG: Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma? Surgery 134: 918-922, 2003.
35. Kema IP, Meiborg G, Nagel GT, Stob GJ and Muskiet FA: Isotope dilution ammonia chemical ionization mass fragmentographic analysis of urinary 3-O-methylated catecholamine metabolites. Rapid sample clean-up by derivatization and extraction of lyophilized samples. J Chromatogr 617: 181-189, 1993.
36. Caballero O, Ferris J, Escobedo JM and Perez A: Gammagraphy with 123I-meta-iodobenzylguanidine in the diagnosis of pheochromocytoma. Med Clin (Barc) 92: 526-529, 1989.
37. de Graaf JS, Nieweg OE, Oosterkamp AE and Zwierstra RP: Results of 25-year pheochromocytoma treatment in the Groningen Academic Hospital. Ned Tijdschr Geneesk 141: 148-151, 1997.
38. Mediavilla Garcia JD, Lopez de la Torre Casares M, Hidalgo Tenorio C, Fernandez-Torres C, Aliaga Martinez L, Peran Mesa F and Muros de Fuentes MA: A comparative study of 9 cases of adrenal pheochromocytoma and 11 cases of extra-adrenal pheochromocytoma. Rev Clin Esp 199: 343-348, 1999.
39. Montravers F, Coutris G, Sarda L, Mensch B and Talbot JN: Utility of thallium-201 and iodine-123 metaiodobenzylguanidine in the scintigraphic detection of neuroendocrine neoplasia. Eur J Nucl Med 20: 1070-1077, 1993.
40. Nielsen JT, Nielsen BV and Rehling M: Location of adrenal medullary pheochromocytoma by I-123 metaiodobenzylguanidine SPECT. Clin Nucl Med 21: 695-699, 1996.
41. Tormey WP, Keeling F and Lee MJ: 123I-metaiodobenzylguanidine scans in phaeochromocytoma diagnosis: current clinical practice and relationship to biochemical screening. Int J Clin Pract 55: 428-432, 1999.
42. Elgazzar AH, Gelfand MJ, Washburn LC, Clark J, Nagaraj N, Cummings D, Hughes J and Maxon HR III: I-123 MIBG scintigraphy in adults. A report of clinical experience. Clin Nucl Med 20: 147-152, 1995.
43. Lynn MD, Shapiro B, Sisson JC, Beierwaltes WH, Meyers LJ, Ackerman R and Mangner TJ: Pheochromocytoma and the normal adrenal medulla: improved visualisation with I-123 MIBG scintigraphy. Radiology 156: 789-792, 1985.
44. Troncone L, Rufini V, Montemaggi P, Danza FM, Lasorella A and Mastrangelo R: The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience. Eur J Nucl Med 16: 325-335, 1990.
45. Rufini V, Troncone L, Valentini AL and Danza FM: A comparison of scintigraphy with radioiodinated MIBG and CT in localizing pheochromocytomas. Radiol Med (Torino) 76: 466-470, 1988.
46. Noblet-Dick M, Grunenberger F, Brunot B, Jaeck D and Schlienger JL: Pheochromocytoma in internal medicine: distinctive features and place of 123I MIBG scintigraphy. Rev Med Intern 24: 358-365, 2003.
47. Lairmore TC, Ball DW, Baylin SB and Wells SA Jr: Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Ann Surg 277: 595-601, 1993.
48. de Graaf JS, Dullaart RP and Zwierstra RP: Complications after bilateral adrenalectomy for phaeochromocytoma in multiple endocrine neoplasia type 2 - a plea to conserve adrenal function. Eur J Surg 765: 843-846, 1999.
49. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G and Angeli A: A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 85: 637-44, 2000.
50. Ilias I, Yu J, Carrasquillo JA, Chen CC, Eisenhofer G, Whatley M, Mc Elroy B and Pacak K: Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 88: 4083-4087, 2003.